MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: BioPharmaceuticals _ Biotechnology, Genomics, Genetics, Bioinformatics, Biomanufacturing & Personalized Medicine, Drug Discovery, Development & Delivery
*Bioscience Regional Clusters & HotSpots
*Industry: Northern California & Silicon Valley
Second Genome, formerly PhyloTech
Parents
*Architects: Biotechnology_Genomics, Multiomics
*Industry: Northern California & Silicon Valley
*Portfolio Companies: Pfizer Venture Systems
Venture Capital: Series A
Children
Has developed a high-throughput platform for rapid and accurate microbiome signature identification and validation
Microbiome-based personalized medicine solutions for gastrointestinal diseases and disorders.
San Francisco, California
Second Genome Announces $5 Million Series (2011)
Second Genome is partnering with academic researchers and manufacturers of novel and existing therapies for gastrointestinal diseases, including developers of probiotic, nutraceutical, and pharmaceutical products, to conduct research on the impact of these
Series A investment co-led by new investors Advanced Technology Ventures (ATV) and Morgenthaler Ventures, and including previous investors Wavepoint Ventures, Seraph Group, and individual Series Seed investors.